Comparison of Enteral Products for Tube Fed Patients With Type 2 Diabetes

Inclusion Criteria: * signed and dated informed consent * diagnosis of type 2 diabetes * HbA1c between 7.0 and 9.0% * 18 - 75 years of age * currently receiving a standard enteral product * anticipated duration on tube feeding at least one month * 100% of patient's nutrient and energy needs are anticipated to be met by enteral nutrition support * anticipated life expectancy is more than or equal to 6 months * free of infections * no change in medications within 2 weeks prior to screening that could profoundly affect blood glucose Exclusion Criteria: * composition of either product is inappropriate for the patient due to allergies or intolerance to any ingredient found in the study products * composition of either product is inappropriate for the patient due to protein, fluid or electrolyte restrictions for concomitant conditions * significant cardiovascular event less than or equal to 2 weeks prior to study entry * major surgery less than or equal to 2 weeks prior to study entry * pre-planned surgery during the study period * active malignancy, including melanoma and excluding cutaneous malignancies * severe dementia * known allergies to medical grade adhesives and/or skin disinfectants * taking octreotide * chronic, contagious, infectious disease, such as active tuberculosis, Hepatitis B or C, or HIV * participation in a concomitant trial